Ani says fda accepts supplemental filing for cortrophin® gel

Ani announces fda acceptance of supplemental filing for cortrophin® gel 80 u/ml.ani pharmaceuticals inc - fda sets prescription drug user fee act (pdufa) goal date of july 23, 2020.

ANIP Ratings Summary

ANIP Quant Ranking